Skip to main navigation Skip to search Skip to main content

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol (BMC Infectious Diseases, (2021), 21, 1, (857), 10.1186/s12879-021-06544-3)

  • The RSV GOLD III—ICU Network Study Group
  • Utrecht University
  • University of Edinburgh
  • Respiratory Syncytial Virus Network (ReSViNET) Foundation

Research output: Contribution to journalComment/debate

Abstract

Following publication of the original article [1], the authors identified an error in the author name of Lynda Abicher. The incorrect author name is: Linda Abicher. The correct author name is: Lynda Abicher. The original article [1] has been corrected.

Original languageEnglish
Article number962
JournalBMC Infectious Diseases
Volume21
Issue number1
DOIs
Publication statusPublished - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol (BMC Infectious Diseases, (2021), 21, 1, (857), 10.1186/s12879-021-06544-3)'. Together they form a unique fingerprint.

Cite this